Corticosteroids

Mechanism of Action Betamethasone + Loratadine It combines the anti-inflammatory and anti-allergic effects of a corticosteroid (betamethasone) with a potent, non-sedating tricyclic antihistamine with peripheral H1 receptor antagonist activity (loratadine). It is indicated for the relief of inflammatory and pruritic manifestations that characterize some atopic dermatoses, angioedema, urticaria, seasonal and perennial allergic rhinitis; food and drug allergic reactions, seborrheic dermatitis, neurodermatitis, allergic asthma, allergic ocular manifestations such as conjunctivitis and iridocyclitis, and allergic reactions to insect bites. The purpose of this combination is to eliminate inflammation through the action of betamethasone and pruritus through the action of loratadine.

Box with 1 ampoule of 2 ml Injectable Solution. It has an anti-inflammatory and immunosuppressive action and is used in the initial treatment of acute/severe autoimmune and dermatological diseases and rheumatoid arthritis. Read the instructions.

Treatment of otitis externa due to infections, eczema, inflammation of various etiologies, seborrheic dermatitis, and contact dermatitis. Due to its subaseptic anti-inflammatory and anesthetic effect, it is used in systemic combinations in comprehensive treatments for non-suppurative otitis media.

Indicated for acute cases and exacerbations in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis; relief of pain and inflammation from acute gouty arthritis, acute and subacute bursitis, tendonitis, and synovitis.

Contains B-COMPLEX/DICLOFENAC Low back pain, myalgia, sciatica, radiculitis, alcoholic polyneuritis, diabetic polyneuritis, torticollis, herpetic neuralgia, peripheral neuralgia, facial neuralgia, trigeminal neuralgia, and intercostal neuralgia. Its current indications are the symptomatic treatment of acute painful conditions (low back pain, sciatica, lumbosciatica), as well as neuritis and polyneuritis. It is the only parenteral medication available that contains this combination and is not approved in any other country in the European Union.

Injectable solution indicated for the treatment of acute and chronic manifestations that do not respond to corticosteroids. It is used in musculoskeletal disorders, allergic conditions, and dermatological conditions.

It is indicated for the treatment of various endocrine, rheumatic, collagen, dermatological, allergic, ophthalmic, gastrointestinal, respiratory, hematological, and other diseases that respond to corticosteroid treatment. Mechanism of Action Betamethasone A synthetic glucocorticoid-type corticosteroid with pronounced anti-inflammatory activity. It influences carbohydrate, protein, and lipid metabolism, electrolyte and water balance, and the functions of the cardiovascular, kidney, musculoskeletal, nervous system, and other organs and tissues, including the blood. Therapeutic Indications Parenteral Betamethasone: Conditions that respond to local or systemic corticosteroid treatment when a sustained effect is required (if appropriate, as an adjunct to basic therapy) and when oral or local treatment is not possible or insufficient, for example: - IM injection in allergic, dermatological, rheumatic, and other conditions that respond to systemic corticosteroids. - Direct injection into the affected tissues in bursitis and inflammatory disorders associated with tendons, such as tenosynovitis, and in inflammatory muscle disorders, such as fibrosis and myositis. - Intra-articular and periarticular injection in rheumatoid arthritis and osteoarthritis. - Intralesional injection in various dermatological conditions and in certain inflammatory and cystic disorders of the foot.

For intra-articular use, BRULIN is indicated for synovitis, osteoarthritis, rheumatoid arthritis, gout, bursitis, and epicondylitis. For intralesional use, Dexamethasone Phosphate is indicated for keloid lesions, inflammatory lesions, hypertrophic infiltrates of lichen planus, discoid lupus, and alopecia areata.

It relieves inflammation (swelling, warmth, redness, and pain) and is used to treat certain forms of arthritis; skin, blood, kidney, eye, thyroid, and bowel disorders (e.g., colitis); severe allergies; and asthma. Dexamethasone is also used to treat certain types of cancer.

ERISPAN is indicated for the treatment of various endocrine, rheumatic, collagen, dermatological, allergic, ophthalmic, gastrointestinal, respiratory, hematological and other diseases that respond to corticosteroid treatment.

Methylprednisolone injectable suspension 40 mg/1 ml is a corticosteroid used to treat a variety of inflammatory and autoimmune conditions. If discomfort persists, consult your doctor.

VENGESIC is indicated for the treatment of acute, chronic and degenerative rheumatic musculoskeletal conditions that involve inflammation, pain and functional disability.

Prednisone 5 mg (brand name Premagnol) is a corticosteroid medication that works by reducing inflammation and suppressing the immune system response. It is primarily used to treat the following conditions: Inflammatory diseases: Such as rheumatoid arthritis, lupus, and various joint conditions. Severe allergies: Treatment of acute allergic reactions, rhinitis, or dermatitis. Respiratory problems: Control of bronchial asthma, inflammation of the bronchi, and other lung diseases. Autoimmune disorders: Diseases where the body attacks itself, such as Crohn's disease or ulcerative colitis. Other conditions: Eye problems, blood disorders, and as supportive treatment for certain types of cancer. Important information for use: Dosage: Must be strictly determined by a doctor, as it varies according to weight and the severity of the condition. Route of administration: Oral. Contraindications: Do not use in cases of fungal infections (systemic mycoses), uncontrolled diabetes, or active peptic ulcers without medical supervision. Side effects: Prolonged treatment may cause fluid retention, increased blood sugar, insomnia, and muscle weakness. For more details, you can consult the Premagnol product information sheet on the PLM website or the Vademecum.

It is indicated for the relief of inflammatory manifestations of dermatoses responsive to corticosteroids, complicated by a secondary infection caused by organisms sensitive to the components of this dermatological preparation or when the possibility of such an infection is suspected.

It is indicated for the relief of inflammatory manifestations of corticosteroid-responsive dermatoses complicated by a secondary infection caused by organisms sensitive to the components of this dermatological preparation, or when the possibility of such an infection is suspected.

Mechanism of Action: Betamethasone Synthetic glucocorticoid-type corticosteroid with pronounced anti-inflammatory activity. It influences carbohydrate, protein, and lipid metabolism, electrolyte and water balance, and the functions of the cardiovascular system, kidneys, musculoskeletal system, nervous system, and other organs and tissues, including the blood. Dexamethasone TAD is a synthetic glucocorticoid. Glucocorticoids are hormones produced by the adrenal cortex. This drug has anti-inflammatory, analgesic, and anti-allergic effects, and suppresses the immune system. Laboratorio Farmaceutica Hispanoamericana